| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Jun 2025 | 3 Jun 2025 |
| Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2025 inter alia to consider and approve To take a note of Resignation of Mr. Bharat Kumar Bohra from the post of Company Secretary & Compliance Officer; To consider and approve appointment of Company Secretary & Compliance Officer; Any other matter with the permission of the Chair. Outcome of Board Meeting held today i.e June 06, 2025 at 11.30 AM at its registered office (As Per BSE Announcement dated on 06.06.2025) | ||
| Board Meeting | 23 May 2025 | 19 May 2025 |
| Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve To consider and approve the Audited Financial Results of the Company along with Auditors Report for the half year and financial year ended March 31 2025; Any other matter with the permission of the Chair. Outcome of Board meeting held on Friday, May 23, 2025 at 11.30 AM for approval of Financial results as on March 31, 2025. (As Per BSE Announcement Dated on 23.05.2025) | ||
| Board Meeting | 25 Mar 2025 | 19 Mar 2025 |
| Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/03/2025 inter alia to consider and approve Appointment of M/s. Kalpesh Khatri and Associates Chartered Accountants as Internal Auditors of the Company; Appointment of M/s. Deep Shukla and Associates as the Secretarial Auditors of the company; Any other matter with the permission of the Chair. With reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held today, i.e., on Tuesday, March 25, 2025, for which intimation was already given to you, the Board of Directors has approved: 1. The appointment of M/s. Kalpesh Khatri & Associates, Chartered Accountants (Firm Regn No: 0139570W) as the Internal Auditor of the Company for a period of 5 years from the Financial Year 2024-25 to Financial Year 2028-29. (The brief profile of Internal Auditor is attached herewith as Annexure I). 2. The appointment of M/s. Deep Shukla &Associates, Practicing Company Secretary, (COP: 5364) as the Secretarial Auditor of the Company for a period of 5 years from the Financial Year 2024-25 to Financial Year 2028-29. (The brief profile of Secretarial Auditor is attached herewith as Annexure II). (As Per BSE Announcement dated on 25.03.2025) | ||
| Board Meeting | 13 Nov 2024 | 6 Nov 2024 |
| Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve To consider and approve the financial results for the period ended September 30 2024 Unaudited Financial results for the half year ended September 30, 2024 (As Per BSE Announcement dated on 13.11.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.